NUVB · Healthcare · $1.9B
Pre-market $5.65+0.89%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“IBTROZI 미국 제품 매출은 전 분기 1,850만 달러에서 25% 늘어난 2,320만 달러로 컨센서스에 맞았고, 매출 감소가 이어진 전체 흐”
In the company's words · 2026 2분기 earnings call